Kai-Uwe Kern Selected Research

Pain (Aches)

5/2022	Ambroxol for neuropathic pain: hiding in plain sight?
1/2022	[Tapentadol versus classical WHO-III opioids for chronic back pain. Health services research study based on representative data from health insurance funds].
1/2021	Oral or Topical Pain Therapy-How Would Patients Decide? A Discrete Choice Experiment in Patients with Peripheral Neuropathic Pain.
3/2020	Tapentadol prolonged release for severe chronic osteoarthritis pain in the elderly: improvements in daily functioning and quality of life.
1/2020	Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain.
1/2019	Topical Ambroxol 20% for the Treatment of Classical Trigeminal Neuralgia - A New Option? Initial Clinical Case Observations.
1/2017	Tapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data.
1/2017	Ambroxol for the treatment of fibromyalgia: science or fiction?
1/2015	Practical considerations for the use of tapentadol prolonged release for the management of severe chronic pain.
7/2014	[Tapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kai-Uwe Kern Research Topics

Disease

14	Pain (Aches) 05/2022 - 08/2011
9	Neuralgia (Stump Neuralgia) 05/2022 - 08/2011
5	Chronic Pain 05/2022 - 07/2014
2	Trigeminal Neuralgia (Tic Douloureux) 05/2022 - 01/2019
2	Complex Regional Pain Syndromes 05/2022 - 11/2018
2	Fibromyalgia (Fibrositis) 05/2022 - 01/2017
2	Hyperalgesia 01/2020 - 01/2013
1	Back Pain (Backache) 01/2022
1	Low Back Pain (Lumbago) 01/2022
1	Osteoarthritis 03/2020
1	Facial Pain (Myofacial Pain) 01/2019
1	Musculoskeletal Pain 01/2017
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2017
1	Hypersensitivity (Allergy) 01/2017
1	Cancer Pain 01/2013
1	Wounds and Injuries (Trauma) 01/2013
1	Postherpetic Neuralgia 01/2013

Drug/Important Bio-Agent (IBA)

6	Analgesics (Analgesic Drugs)IBA 05/2022 - 07/2014
5	Tapentadol FDA Link 01/2022 - 07/2014
5	Capsaicin (Zostrix)FDA Link 01/2020 - 08/2011
4	Ambroxol (Mucosolvan)IBA 05/2022 - 01/2017
3	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2015
2	Pharmaceutical PreparationsIBA 05/2022 - 11/2018
2	Opioid Receptors (Opioid Receptor)IBA 01/2017 - 01/2015
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2017 - 01/2015
2	Oxycodone (Oxycontin)FDA LinkGeneric 01/2017 - 07/2014
2	Naloxone (Narcan)FDA LinkGeneric 01/2017 - 07/2014
2	Lidocaine (Xylocaine)FDA LinkGeneric 02/2014 - 01/2013
1	Pregabalin (Lyrica)FDA Link 01/2020
1	Sodium Channels (Sodium Channel)IBA 01/2019
1	Biological ProductsIBA 01/2017

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2015
2	Analgesia 01/2015 - 07/2014
1	Drug Tapering 01/2013
1	Drug Therapy (Chemotherapy) 01/2013